Fact-checked by Grok 2 weeks ago

Linoleic acid

Linoleic acid is a polyunsaturated with the molecular C₁₈H₃₂O₂ and the IUPAC name (9Z,12Z)-octadeca-9,12-dienoic acid, featuring an 18-carbon with two double bonds at positions 9 and 12. As an , it cannot be synthesized by the and must be obtained from dietary sources, where it serves as a precursor to longer-chain polyunsaturated fatty acids like . It plays critical roles in maintaining integrity, supporting skin barrier function, and regulating through the production of eicosanoids. Linoleic acid is vital for human physiology, with deficiency—rare in modern diets—leading to symptoms such as dry skin, , and impaired . Primary dietary sources include vegetable oils (e.g., , sunflower, corn, ), nuts, and seeds, contributing 5–10% of total energy intake in typical Western diets. Adequate intake is associated with reduced risk, potentially through lowering , though excessive consumption relative to omega-3 fatty acids may promote pro-inflammatory pathways. Recent meta-analyses as of 2025 reinforce links to lower risks of and improved cardiometabolic health. Ongoing research explores its roles in metabolic and neurological functions.

Chemical properties

Structure and nomenclature

Linoleic acid is a straight-chain with the molecular formula \ce{C18H32O2}. Its systematic IUPAC name is (9,12)-octadeca-9,12-dienoic acid, reflecting the 18-carbon chain (octadeca-) with double bonds at positions 9 and 12 in the Z () configuration. The common name "linoleic" derives from the Greek word linon () and oleic (relating to ), as it was first isolated from , the oil extracted from flax seeds. As a polyunsaturated fatty acid (PUFA), linoleic acid features multiple carbon-carbon s along its chain, specifically two nonconjugated double bonds separated by a (methylene-interrupted), which imparts flexibility and reactivity distinct from saturated fatty acids lacking such unsaturations. The consists of a carboxyl group (-COOH) at carbon 1, followed by a chain of 17 methylene (-CH2-) and methyl (-CH3) groups, with the double bonds positioned between carbons 9-10 and 12-13 when numbered from the carboxyl end; from the methyl end, the terminal double bond starts at position 6, classifying it as an . This omega-6 designation highlights its role within the family of essential fatty acids, where the position of unsaturation influences metabolic pathways. Linoleic acid exists in various isomeric forms differing in positions, configurations ( or ), or conjugation. The standard form is nonconjugated, with isolated s separated by two s, whereas (CLA) comprises geometric and positional isomers featuring conjugated s (separated by a ), such as (9Z,11E)-octadeca-9,11-dienoic acid, which alters and compared to the nonconjugated parent compound.

Physical characteristics

Linoleic acid appears as a colorless to straw-yellow at . It possesses a mild fatty . The compound has a of -5 °C and a of 230 °C at reduced pressure (16 mmHg). Its density is 0.902 g/cm³ at 25 °C, and the is 1.466 at 20 °C (sodium D line). Linoleic acid is insoluble in (solubility approximately 0.14 mg/L at 25 °C) but exhibits good solubility in organic solvents such as , , acetone, , and ethyl ether. Due to its two unconjugated bonds, linoleic acid is susceptible to oxidation, which can lead to rancidity and the formation of peroxides upon exposure to air, light, or heat. To maintain stability and prevent peroxidation, it should be stored in a cool, dark place under an inert atmosphere such as .

Synthesis and reactions

In , linoleic acid is biosynthesized through the desaturation of (18:1 Δ9) by the endoplasmic reticulum-localized 2 (FAD2), also known as Δ12-desaturase, which introduces a at the Δ12 position to yield linoleic acid (18:2 Δ9,12). This enzymatic step occurs primarily in the desaturation-elongation cycle of within plant cells, with FAD2 expression regulated by factors such as temperature and developmental stage to optimize and seed oil composition. Commercially, linoleic acid is obtained through partial chemical processing of high-linoleic oils, such as oil, which contains up to 75-80% linoleic acid as triglycerides. The process involves mechanical pressing or solvent extraction of the oil followed by to free fatty acids, complexation or for purification, and to isolate linoleic acid, yielding products of 95% or higher purity for industrial use. Linoleic acid undergoes several key chemical reactions due to its polyunsaturated nature. Hydrogenation, typically catalyzed by nickel or palladium under hydrogen gas, reduces the double bonds to produce saturated derivatives like stearic acid (18:0) or partially hydrogenated intermediates such as oleic acid, a process widely used to solidify oils for margarine production. Esterification with glycerol forms linoleic acid triglycerides via acid- or enzyme-catalyzed reactions, while reaction with lysophospholipids or diacylglycerols incorporates it into phospholipids, essential for lipid assembly in biological and food applications. Oxidation of linoleic acid proceeds via a free radical chain mechanism during autoxidation, where molecular oxygen abstracts a hydrogen from the allylic methylene (positions 11 or 14), leading to peroxyl radical formation and subsequent addition of O₂ to produce hydroperoxides. The primary products are 9-hydroperoxy-10E,12Z-octadecadienoic acid and 13-hydroperoxy-9Z,11E-octadecadienoic acid, as represented by the simplified equation: \ce{(CH3(CH2)4CH=CHCH2CH=CH(CH2)7COOH + O2 ->[free radical] hydroperoxy derivatives} This peroxidation is a major pathway in rancidity and . Under alkaline conditions or thermal , linoleic acid isomerizes to (CLA) isomers, such as 9Z,11E-octadecadienoic acid, by shifting the double bonds from the skipped (methylene-interrupted) to conjugated positions through proton abstraction and reprotonation. This reaction, often performed with in , produces a mixture of CLA isomers used in nutraceuticals.

Occurrence and sources

Natural occurrence

Linoleic acid is a ubiquitous polyunsaturated found in high concentrations in the seeds and oils of numerous species, where it serves as a primary component of storage lipids. In oil, it comprises 70-78% of total fatty acids, while oil contains approximately 68-70% linoleic acid. These elevated levels contribute to the oils' roles in and . In animal tissues, linoleic acid occurs at relatively low levels, particularly in non-ruminants, where it is not endogenously synthesized but incorporated from dietary sources and subsequently elongated or desaturated to form longer-chain polyunsaturated fatty acids such as . Concentrations in non-ruminant meats, such as or , typically range below 20% of total fatty acids in muscle , reflecting dependence on plant-based feed. In contrast, microorganisms like the oleaginous Mortierella alpina produce substantial amounts, with linoleic acid accounting for up to 42% of its lipid profile under optimal conditions. Linoleic acid plays key roles in , primarily by enhancing through its incorporation into phospholipids, which allows for proper protein function and adaptation to environmental stresses. It also participates in signaling pathways, serving as a precursor for oxylipins involved in defense responses against pathogens and abiotic factors. In ecosystems, linoleic acid contributes to environmental cycling via its presence in lipids, where it forms part of the derived from roots and microbial activity, and in , such as blue-green algae , comprising variable but significant portions (up to 10-20%) of their content to support photosynthetic integrity. Non-edible natural sources further illustrate its widespread distribution, including wood resins where linoleic acid is a representative extractive (typically 5-15% of fraction in coniferous ) aiding in structural protection, and insect cuticles, where it integrates into the barrier (around 10-30% in some ) to regulate permeability and prevent .

Dietary sources

Linoleic acid is abundant in various vegetable oils, which serve as primary dietary sources for this . Safflower oil contains approximately 74 g of linoleic acid per 100 g, while provides about 54 g per 100 g. Nuts and seeds also contribute significantly; for example, sunflower seeds offer around 23 g per 100 g. Meats, particularly , provide smaller amounts, with containing 0.2–1.5 g per 100 g depending on the cut and preparation. According to WHO/FAO guidelines, linoleic acid should provide at least 2.5% of total energy intake (approximately 5–6 g/day for adults assuming –2500 kcal diets) to prevent deficiency. Western diets typically meet or exceed this level through widespread use of processed foods and vegetable oils, though excessive intake from ultra-processed sources may pose risks. Many commercial products are fortified with linoleic acid to enhance nutritional profiles. Margarines often incorporate oils rich in linoleic acid to replace fats, providing 10–20 g per 100 g in some formulations. formulas are similarly fortified to mimic composition, typically including 7–12% of total fatty acids as linoleic acid to support early development. Dietary patterns vary regionally, influencing linoleic acid consumption. In Mediterranean diets, intake is moderated at around 3–4% of energy from sources like blends and nuts, balancing omega-6 with higher monounsaturated fats.

Industrial production

Linoleic acid is primarily produced on an scale through extraction from high-linoleate vegetable oils, such as , which typically contains about 50-51% linoleic acid by weight. The process begins with mechanical pressing or extraction of oilseeds using , a non-polar that efficiently dissolves from the seed matrix, followed by under vacuum to separate the crude oil and recover the . This method yields a mixture with approximately 50% linoleic acid purity from sources, making it cost-effective for large-scale operations due to the abundance of oilseed crops. Global production of linoleic acid exceeds 1 million tons annually, primarily derived from oilseed crops like soybeans and sunflowers, with major producers including the and , which together account for over 45% of output. In the , soybean processing contributes significantly, while dominates through extensive refining. These volumes support applications in , pharmaceuticals, and food additives, driven by the economic viability of plant-based extraction. For higher-purity isolates required in specialized applications, purification techniques such as complexation and are employed on the crude extracts. complexation exploits the differential solubility of saturated and monounsaturated fatty acids in solutions, allowing polyunsaturated linoleic acid to remain in the non-complexed fraction; optimal conditions using a urea-to-fatty acids ratio of 0.94 in 95% achieve up to 87.8% purity with 83.4% recovery from . , including silver-ion or preparative methods, further refines the product to over 95% purity, as demonstrated in separations from crude yielding 95.2% linoleic acid. Alternative biotechnological approaches involve microbial using engineered organisms to produce linoleic acid, offering potential sustainability benefits over traditional extraction. Engineered yeasts, such as with overexpressed desaturases and lipases, have achieved enhanced linoleic acid accumulation through modifications. Similarly, oleaginous algae like can be optimized for linoleic acid production via controlled , though these methods remain in stages and are not yet commercially dominant.

Biological role

Essentiality as a nutrient

Linoleic acid is classified as an because humans and other mammals cannot synthesize it endogenously and must obtain it from the diet. It serves as the primary precursor for the omega-6 family of polyunsaturated fatty acids, which are crucial for maintaining integrity, supporting production, and facilitating various physiological processes. The essentiality of linoleic acid stems from the human body's inability to introduce double bonds at positions beyond the delta-9 carbon in chains. Specifically, humans lack the required to convert (18:1 n-9) into linoleic acid (18:2 n-6), necessitating a dietary supply to meet physiological needs. Deficiency of essential fatty acids, including linoleic acid, was first demonstrated in historical by George and Mildred Burr in 1929–1930, where rats fed fat-free diets exhibited symptoms such as scaly , growth retardation, , impaired , and reproductive failure. In humans, similar manifestations occur with prolonged inadequate intake, including dry, scaly skin (often resembling phrynoderma), alopecia, poor , and growth retardation in children, particularly in cases of or without lipid supplementation. To prevent deficiency, the minimum dietary requirement for linoleic acid is approximately 1% of total energy intake for infants and 0.5–2% for adults, though adequate intake recommendations are higher to support optimal health. Biomarkers of deficiency include a exceeding 0.2 in phospholipids and linoleic acid levels below 0.5% of total fatty acids, indicating biochemical impairment.

Metabolism in humans

Linoleic acid, an omega-6 polyunsaturated , is primarily absorbed in the small intestine through a process involving mixed micelles formed by salts, phospholipids, and dietary , which solubilize the and facilitate its uptake by enterocytes via passive diffusion and protein-mediated transport, such as and fatty acid-binding proteins. Once inside enterocytes, linoleic acid is re-esterified into triglycerides and incorporated into chylomicrons, which are then secreted into the and enter the bloodstream via the for distribution to tissues. Following absorption, linoleic acid undergoes enzymatic metabolism primarily in the liver and other tissues, where it serves as a precursor for longer-chain polyunsaturated fatty acids. The initial step involves delta-6 desaturase (encoded by FADS2), which introduces a to convert linoleic acid (18:2 n-6) to (, 18:3 n-6); this is followed by via elongase enzymes to produce dihomo-gamma-linolenic acid (DGLA, 20:3 n-6). \text{Linoleic acid (18:2 n-6)} \xrightarrow{\Delta^6\text{-desaturase}} \gamma\text{-linolenic acid (18:3 n-6)} This pathway is rate-limited by delta-6 desaturase activity and competes with omega-3 fatty acids for the same enzymes. Linoleic acid and its metabolites are distributed throughout the body, with high incorporation into phospholipids of membranes, where it contributes to and signaling, and storage in as triglycerides, reflecting long-term dietary intake. Several factors influence linoleic acid metabolism in humans, including , which is associated with declining delta-6 desaturase activity and reduced efficiency, leading to lower levels of downstream metabolites. Genetic variations, particularly polymorphisms in FADS1 and FADS2 genes, significantly modulate desaturase activity and thus the efficiency of linoleic acid to GLA and DGLA, with certain variants resulting in lower endogenous production. Additionally, high dietary intake of omega-3 fatty acids competes with linoleic acid for delta-6 desaturase, potentially reducing its metabolic flux.

Bioactive derivatives

Linoleic acid undergoes enzymatic conversion to through alternating desaturation and elongation reactions, positioning it as a central precursor for bioactive eicosanoids involved in cellular signaling. The process begins with Δ6-desaturation of linoleic acid (18:2 n-6) to γ-linolenic acid (18:3 n-6), followed by elongation to dihomo-γ-linolenic acid (20:3 n-6), and concludes with Δ5-desaturation to (20:4 n-6). This pathway, primarily occurring in the liver and other tissues, relies on elongases (e.g., ELOVL5) for the carbon chain extension step. Arachidonic acid is subsequently metabolized via two major pathways to generate eicosanoids. The (COX) pathway, catalyzed by COX-1 and COX-2 enzymes, produces prostaglandins such as (PGE2) and (TXA2). In parallel, the (LOX) pathway, involving enzymes like 5-LOX and 15-LOX, yields leukotrienes (e.g., LTB4) from , while 15-LOX directly oxidizes linoleic acid to 13-hydroxyoctadecadienoic acid (13-HODE), an oxylipin derivative. The elongation in the upstream pathway can be represented as: \text{γ-linolenic acid (18:3 n-6)} + 2\text{C} \xrightarrow{\text{elongase (ELOVL)}} \text{dihomo-γ-linolenic acid (20:3 n-6)} Followed by desaturation to arachidonic acid. These bioactive derivatives exert regulatory effects on key physiological processes. For instance, prostacyclin (PGI2), derived from arachidonic acid via COX, promotes vasodilation by relaxing vascular smooth muscle cells. Thromboxane A2 facilitates platelet aggregation to support hemostasis, while prostaglandins like PGE2 modulate cytokine production, influencing immune cell activation and inflammatory signaling.

Health effects

Cardiovascular and metabolic impacts

Linoleic acid (LA), an essential omega-6 polyunsaturated fatty acid, has been extensively studied for its role in modulating cardiovascular risk factors, particularly through improvements in profiles. Meta-analyses of prospective studies indicate that higher dietary LA intake is inversely associated with coronary heart disease (CHD) events and mortality; for instance, each 5% increase in energy from LA replacing saturated fats or carbohydrates is linked to a 9% reduction in CHD events and a 13% lower risk of CHD death. Similarly, circulating levels of LA show a dose-response relationship with reduced progression, as LA-enriched diets lower (LDL) cholesterol by promoting its clearance and reducing oxidation in arterial walls. A 2023 confirmed that dietary LA supplementation decreases total and LDL-C levels, with the effect more pronounced in younger individuals and those with lower , thereby mitigating plaque formation and vascular inflammation. In metabolic health, LA contributes to enhanced insulin sensitivity and a lower incidence of (T2D) by altering composition. Incorporation of LA into phospholipids increases , facilitating greater binding and downstream signaling for . A 2021 meta-analysis of studies found that higher LA intake correlates with a 6% reduced risk of T2D per standard deviation increase, supported by randomized trials showing improved glycemic control and indices in LA-rich diets. This protective effect is evident in recent prospective data from the , where moderate LA consumption (around 5-7% of total energy) was associated with better glucose regulation and reduced T2D progression in diverse populations. The balance between omega-6 and omega-3 fatty acids is crucial for these benefits, with the omega-6/omega-3 influencing and cardiovascular outcomes. An optimal of approximately 4:1 has been linked to a 70% decrease in total mortality in secondary prevention trials, while ratios exceeding 10:1—common in Western diets—are associated with , elevated triglycerides, and heightened CHD risk due to pro-inflammatory imbalances. Maintaining a lower enhances LA's favorable effects on endothelial function and . Key clinical evidence includes the Sydney Diet Heart Study from the , which tested LA-enriched safflower oil replacement of saturated fats in post-heart attack patients and showed lowered serum but increased all-cause mortality (17.6% vs. 11.8%; HR 1.62) and cardiovascular mortality (17.2% vs. 11.0%; HR 1.70) compared to control, indicating potential harm from high LA doses without omega-3 balancing. In contrast, recent cohort studies and meta-analyses from the , such as those analyzing large U.S. and European datasets, confirm cardiovascular benefits at moderate LA levels (2-5% energy intake), with up to 15-20% lower CVD event rates when substituting saturated fats, underscoring the importance of dietary context.

Inflammatory and immune responses

Linoleic acid (LA), an essential omega-6 polyunsaturated fatty acid, plays a dual role in through its conversion to (AA), which serves as a precursor for both pro-inflammatory and pro-resolving eicosanoids. AA is metabolized via the 5- (5-LOX) pathway to produce (LTB4), a potent chemoattractant that amplifies recruitment and release during acute . In contrast, balanced LA metabolism can lead to anti-inflammatory derivatives, such as lipoxins generated from AA via the pathway, which actively promote by inhibiting further leukocyte influx and enhancing . This duality underscores LA's context-dependent effects, where excessive AA-derived pro-inflammatory signaling predominates in dysregulated states, while equilibrated pathways support . Studies in disease models highlight LA's variable impact on inflammatory cytokines. In cystic fibrosis models, elevated LA intake increases AA conversion, elevating pro-inflammatory eicosanoids and cytokines like interleukin-8, exacerbating airway inflammation. Similarly, high LA-derived AA has been linked to heightened cytokine production in arthritis-like conditions, where omega-6 enrichment amplifies joint inflammation through LTB4-mediated pathways. Conversely, LA exhibits protective effects in allergic responses; its metabolites modulate T helper 2 (Th2)-biased immunity, reducing hypersensitivity by altering long-chain polyunsaturated fatty acid consumption during allergic inflammation and shifting toward Th1 dominance. LA incorporation into immune cell membranes enhances T-cell functionality and adaptive immunity. By integrating into bilayers, LA improves CD8+ T-cell metabolic fitness, boosting and preventing exhaustion, which in turn promotes memory-like and antitumor . This membrane modulation also supports production indirectly through optimized T-cell help to B cells, as seen in enhanced humoral responses in LA-supplemented models. Recent post-2020 meta-analyses confirm no net elevation in markers at recommended dietary intakes (around 12-17 g/day), with higher LA levels associated with reduced all-cause and cardiovascular mortality, suggesting overall anti-inflammatory benefits in balanced diets. However, in contexts of ultra-processed foods—where LA from seed oils combines with high glycemic loads—oxidized LA metabolites accumulate, potentially heightening inflammatory risks through mitochondrial dysfunction and . Emerging research as of 2025 suggests potential risks from excessive linoleic acid intake, including associations with higher cancer incidence through mechanisms like and pro-inflammatory eicosanoids, and (PCOS)-like changes in models, though clinical remains limited and debated. Conversely, other 2024-2025 reviews reaffirm cardiometabolic benefits at moderate levels.

Skin and other physiological effects

Linoleic acid plays a critical role in maintaining barrier function through its incorporation into ceramides, particularly the ester-linked omega-hydroxy (EOS) ceramides that form the lipid lamellae of the . These ceramides, esterified with linoleic acid, provide structural integrity and prevent (TEWL), with deficiencies leading to impaired barrier recovery and conditions like deficiency (EFAD) . Topical application of linoleic acid, often at concentrations around 2-3% in formulations, has been shown to normalize follicular hyperkeratinization in acne vulgaris by reducing comedone formation and improving lesion severity, while also accelerating barrier repair in eczema when combined with ceramides. For instance, linoleic acid-enriched moisturizers reduce TEWL by up to 20-30% in patients, enhancing hydration and alleviating itch without significant adverse effects. In reproduction, linoleic acid contributes to as a major (PUFA) component, facilitating and necessary for fertilization; higher linoleic acid levels correlate with improved and outcomes in models and studies. During fetal development, maternal linoleic acid supports placental transfer of n-6 PUFAs, aiding embryonic formation and early , with deficiencies linked to increased risks of and . Neurologically, linoleic acid serves as a precursor to n-6 docosapentaenoic acid (DPA), which is incorporated into phospholipids and sheaths, potentially supporting neuronal insulation and signaling; however, human data remain limited, with most evidence from models showing elevated n-6 DPA in lipids under linoleic acid supplementation. Recent studies from the highlight linoleic acid's potential in via promotion of and deposition, as seen in topical applications that accelerate full-thickness recovery by stimulating . Additionally, emerging research suggests linoleic acid influences the gut-skin axis by modulating microbial-derived metabolites that affect skin , though clinical trials are ongoing. In , linoleic acid is commonly incorporated into lotions at 1-5% to bolster barrier function and hydration, often derived from oils like sunflower or for anti-aging and emollient effects.

History and research

Discovery and early characterization

Linoleic acid was first isolated in 1844 from by F. Sacc in the laboratory of , where it was identified as an based on its chemical properties and reactivity. The name "linoleic acid" originates from the Latin words (flax) and oleum (oil), highlighting its derivation from flaxseed (. In 1929, George O. Burr and Mildred M. Burr conducted pioneering experiments on rats fed a fat-free , observing a deficiency characterized by growth retardation, skin lesions, and reproductive failure, which they attributed to the absence of specific unsaturated fatty acids. They demonstrated that supplementing the with linoleic acid prevented and cured this , establishing linoleic acid as an essential nutrient required in small amounts for normal health and growth. This work marked a , proving that certain fatty acids are indispensable dietary components, as mammals cannot synthesize them . During the 1930s and 1940s, the of linoleic acid was elucidated through a series of analytical techniques, including , bromination, and . Researchers such as T. P. Hilditch and colleagues confirmed the positions of the two s at carbons 9 and 12 (counting from the carboxyl end), establishing it as all-cis-9,12-octadecadienoic acid. , in particular, proved instrumental in cleaving the double bonds to yield identifiable fragments like and pelargonaldehyde, providing direct evidence for the double bond locations. These studies also revealed early nomenclature variations, with linoleic acid initially described by its delta notation (Δ9,12) before being recognized as the parent compound of the family due to the position of its terminal double bond (counted from the methyl end). The omega-6 designation, formalized in subsequent decades, underscored its role in the biosynthetic pathway leading to longer-chain polyunsaturated fatty acids like .

Modern studies and controversies

In the mid-20th century, several large randomized controlled trials examined the impact of increasing linoleic acid intake through vegetable oils on outcomes, yielding mixed results that fueled ongoing debates. The Coronary Experiment (1968–1973), involving 9,423 participants in nursing homes and mental hospitals, tested replacing saturated fats with providing about 13% of energy from linoleic acid; while serum decreased by 13.8% in the intervention group, there was no reduction in coronary heart disease mortality, and all-cause mortality was 22% higher for each 30 mg/dL reduction. Similar findings emerged from the Diet Heart Study (1966–1973), where linoleic acid enrichment (15% of energy) lowered but increased cardiovascular mortality by 77% (HR 1.77) compared to the control group. These results, published or reanalyzed in the and , prompted caution against excessive omega-6 polyunsaturated consumption, influencing dietary guidelines to emphasize balance with omega-3s rather than unrestricted linoleic acid intake. Advancements in the shifted focus to genetic influences on linoleic acid , revealing interpersonal variability in its conversion to bioactive derivatives. Polymorphisms in the FADS gene cluster, particularly rs174537 near FADS1 and FADS2, were strongly associated with desaturase activity; carriers of minor alleles exhibited up to 20–30% lower plasma levels of derived from linoleic acid, affecting cardiometabolic responses to dietary . These insights informed personalized research. Paralleling this, meta-analyses from the onward affirmed cardiovascular benefits at moderate levels: a of 32 studies found that each 5% increase in energy from linoleic acid correlated with a 15% reduction in coronary heart disease events, supporting intakes of 5–10% of total energy without adverse effects. Controversies surrounding linoleic acid intensified in the , with claims that its abundance in industrialized seed oils promotes and diseases like cancer, though recent evidence has largely refuted these. Pro-inflammatory hypotheses, based on arachidonic acid's role in production, were challenged by a 2012 systematic review of 15 randomized trials (referenced in a 2018 analysis), which found no increase in inflammatory markers (e.g., C-reactive protein or interleukin-6) with linoleic acid supplementation up to 10% of energy. For cancer, data from the European Prospective Investigation into Cancer and Nutrition () cohort, involving over 500,000 participants, showed no positive association; a incorporating results indicated a modest, non-significant reduction in risk (RR 0.97 per 5 g/day higher linoleic acid intake), with neutral or inverse links for other sites. Persistent concerns focus on seed oil processing, where high-heat extraction may generate oxidized linoleic acid metabolites that damage and exacerbate , as proposed in mechanistic reviews linking these to coronary heart disease progression. Significant research gaps hinder a complete understanding of linoleic acid's long-term implications. Human trials on intakes exceeding 10% of energy are scarce, with most data limited to 1–5 years, leaving uncertainties about chronic effects on oxidative stress or insulin sensitivity. Interactions with the gut microbiome remain underexplored, though rodent studies suggest high-linoleic diets alter endocannabinoid signaling and microbial composition, potentially heightening colitis risk without clear human translation. Sustainability issues in seed oil production, including high water use and land conversion for crops like soybeans, underscore needs for eco-friendly sourcing. Emerging vegan supplement research, such as fortified algal oils providing balanced omega-6 without animal-derived arachidonic acid precursors, shows promise for optimizing intake in plant-based diets, but lacks longitudinal efficacy data. As of 2025, recent reviews and cohort studies continue to support that higher linoleic acid intake is associated with reduced risks of cardiovascular disease and type 2 diabetes, with no evidence of increased inflammation.

References

  1. [1]
    Linoleic Acid | C18H32O2 | CID 5280450 - PubChem - NIH
    It has a role as a plant metabolite, a Daphnia galeata metabolite and an algal metabolite. It is an omega-6 fatty acid and an octadecadienoic acid.
  2. [2]
    Essential Fatty Acids | Linus Pauling Institute | Oregon State University
    In particular, the antioxidative and anti-inflammatory properties of these PUFA may help protect neurons, promote synaptic plasticity, and limit cellular death.
  3. [3]
    Linoleic Acid: A Narrative Review of the Effects of Increased Intake ...
    LA is a major constituent of human tissues [2], and it is considered to be an essential fatty acid. Deficiencies in essential fatty acid intake among adults ...
  4. [4]
    Effects of Dietary Linoleic Acid on Blood Lipid Profiles - NIH
    May 25, 2023 · Previous meta-analyses have shown that increasing n-6 fat can lower the blood TC without affecting TG, HDL, or LDL [19]. However, there are some ...
  5. [5]
    Linoleic Acid and the Regulation of Glucose Homeostasis
    Linoleic acid (LA, ω−6 18:2) is an essential fatty acid that accounted for 1–2% of total energy intake in the pre-industrial revolution human diet. Since the ...<|control11|><|separator|>
  6. [6]
    Showing metabocard for Linoleic acid (HMDB0000673)
    Nov 16, 2005 · Average Molecular Weight, 280.4455 ; Monoisotopic Molecular Weight, 280.240230268 ; IUPAC Name, (9Z,12Z)-octadeca-9,12-dienoic acid ; Traditional ...
  7. [7]
    Linoleic Acid
    The word linoleic comes from the Greek word linon (flax), and oleic meaning relating to or derived from oil. Essential Fatty Acids. Linoleic acid belongs to ...
  8. [8]
    Linoleic acid (C18H32O2) properties
    Linoleic acid, systematically named (9Z,12Z)-octadeca-9,12-dienoic acid with molecular formula C₁₈H₃₂O₂, represents a polyunsaturated omega-6 fatty acid of ...
  9. [9]
    Conjugated linoleic acid isomers: differences in metabolism and ...
    The term conjugated linoleic acid (CLA) refers to a mixture of linoleic acid positional and geometric isomers, characterized by having conjugated double ...
  10. [10]
    linoleic acid, 60-33-3 - The Good Scents Company
    It is a pale, oily liquid with low odor, and is highly resistant to discoloration on exposure to heat and light. Because of the near absence of saturated fatty ...
  11. [11]
  12. [12]
    Linoleic Acid - an overview | ScienceDirect Topics
    Due to multiple double bonds, polyunsaturated fatty acids (principally linolenic acid and to a lesser degree linoleic acid) are also oxidatively unstable.
  13. [13]
    Lipid oxidation in foods and its implications on proteins - PMC - NIH
    Jun 15, 2023 · Lipid oxidation is one of the leading causes of food spoilage. It refers to how unsaturated fatty acids in fats are slowly oxidized when exposed ...
  14. [14]
    and Double-Fractionated Olein of Safflower Oil Produced by Low ...
    Among all sources of vegetable oils, safflower oil (SO) possesses the maximum linoleic acid content. To boost the industrial applications of SO, two ...
  15. [15]
    linoleic acid - Organic Syntheses Procedure
    The linoleic acid rises to the surface as a clear layer. The water layer is siphoned off; the acid is washed once with hot water and then dried over anhydrous ...
  16. [16]
    Catalytic hydrogenation of linoleic acid to stearic acid over different Pd
    Aug 1, 2008 · Catalytic hydrogenation of linoleic acid in n-decane as a solvent was studied over several Pd- and Ru-supported catalysts in order to achieve complete ...Missing: reaction | Show results with:reaction
  17. [17]
    Optimization of conjugated linoleic acid triglycerides via enzymatic ...
    Nov 7, 2009 · The triglycerides were synthesized by esterification of glycerol and conjugated linoleic acid (CLA) in a no-solvent system using lipase ...
  18. [18]
    Isomers of Conjugated Fatty Acids. I. Alkali-isomerized Linoleic Acid
    Direct Isomerization of Linoleic Acid to Conjugated Linoleic Acids (CLA) using Gold Catalysts. Chemical Engineering & Technology 2009, 32 (12) , 2005-2010 ...
  19. [19]
    Oils Rich in Linoleic Acid - News-Medical
    Linoleic acid (alongside oleic acid) represents major unsaturated fatty acid present in practically all oils. Peanut, cotton and corn oils display higher ...
  20. [20]
    Fatty acid composition and tocopherol profiles of safflower ... - PubMed
    The major fatty acid of safflower oil is linoleic acid, which accounted for 55.1-77.0% in oils, with a mean value of 70.66%.
  21. [21]
    Sunflower Oil: 3 Different Grades For The Food Industry
    Sep 17, 2018 · Linoleic acid is one of the essential fatty acids in the human diet, and linoleic varieties of sunflower oil contain nearly 70 percent ...
  22. [22]
    Contents of Conjugated Linoleic Acid Isomers cis9,trans11 and ...
    Being non-ruminant animals, pork and horse meats showed c9,t11 CLA levels lower than 1 mg/g fat, in agreement with previous studies (Schmid et al., Citation2006) ...
  23. [23]
    Lipid metabolism research in oleaginous fungus Mortierella alpina
    Microbial production of dihomo-γ-linolenic acid by Δ5-desaturase gene-disruptants of Mortierella alpina 1S-4. Journal of Bioscience and Bioengineering ...
  24. [24]
    Effect of low-cost substrate on the fatty acid profiles of Mortierella ...
    Each formulated media significantly affected the profiles of M. alpina fatty acids. The highest content of linoleic acid (41.873%), oleic acid (30.061%) and ...<|separator|>
  25. [25]
    Linoleic Acid - PMC - NIH
    May 6, 2013 · Like all fatty acids, it can be used as a source of energy. It can be esterified to form neutral and polar lipids such as phospholipids, ...
  26. [26]
    Plant Unsaturated Fatty Acids: Multiple Roles in Stress Response
    Nitro-fatty acids in plant signaling: Nitro-linolenic acid induces the molecular chaperone network in Arabidopsis. ... Opposite changes in membrane fluidity ...Abstract · Introduction · Multiple Roles of C18... · Genetic Engineering of Fatty...
  27. [27]
    Linoleic Acid - an overview | ScienceDirect Topics
    Linoleic acid (LA) (n−6) and α-linolenic acid (ALA) (n−3) are essential ... Chemical structure of gallic acid. IUPAC name: 3, 4,5-trihydroxybenzoic acid.Missing: classification | Show results with:classification
  28. [28]
    Examples of extractive components in wood – fatty acids ...
    Examples of extractive components in wood – fatty acids represented by linoleic acid, resin acids represented by abietic acid, and the esterified compounds ...
  29. [29]
    Linoleic Acid, Vitamin E and Other Fat-Soluble Substances in the ...
    Without linoleic acid there is no emergence, with very little linoleic acid the cuticles separate, but the scales remain stuck to the wrong cuticle, and ...
  30. [30]
    [PDF] Fats and fatty acids in human nutrition
    Recommended dietary intakes for total fat and fatty acid intake for adults. 56. TABLE 6.1. Recommended dietary intakes for total fat and fatty acid: infants. (0 ...
  31. [31]
    The Contribution of Modern Margarine and Fat Spreads to Dietary ...
    Feb 24, 2016 · Role of linoleic acid in infant nutrition: clinical and chemical study of 428 infants fed on milk mixtures varying in kind and amount of fat.Recommended Fat Intake · Polyunsaturated Fatty Acids · Improving Margarine Products...
  32. [32]
    Moving Toward Desirable Linoleic Acid Content in Infant Formula
    This paper provides a narrative review of the current knowledge, unresolved questions, and future research needs in the area of HM fatty acid (FA) composition.
  33. [33]
    How Much Linoleic Acid Do You Need? - The Paleo Diet®
    Nov 29, 2021 · ... diet with 5.3 percent linoleic acid or to a so-called Mediterranean diet with 3.6 percent linoleic acid. [18] The diets differed in many ...
  34. [34]
    Understanding Hexane Extraction of Vegetable Oils
    Jul 31, 2023 · Hexane is the primary solvent used to extract edible and industrial vegetable oils from the world's top five commodity oilseeds: soybean, canola, sunflower ...
  35. [35]
    Soybean Oil Health Benefits | Nutritional Insights - Soy Connection
    The PUFA is comprised of 5 to 7 percent alpha-linolenic acid (ALA), the essential omega-3 fatty acid, and about 50% linoleic acid (LA), the essential omega-6 ...Phytosterols · Vitamin-E · Dietary Fat, Coronary Heart...
  36. [36]
    Linoleic Acid (LA) Market Size - Industry Trends Report 2018-2024
    Linoleic Acid Market Size. Linoleic acid Market size was over USD 2.2 billion in 2017 and industry expects consumption of above 1 million tons by 2024.Missing: annual | Show results with:annual
  37. [37]
    Linoleic Acid Market Report | Global Insights [2034]
    Oct 29, 2025 · China held 24% share with 420,000 tons and a CAGR of 7.6%, dominating vegetable oil-based linoleic acid production. United States captured 21% ...
  38. [38]
    Optimizing Conditions for the Purification of Linoleic Acid from ...
    May 31, 2008 · The separation and purification of linoleic acid (LA) from sunflower seed oil by urea complex fractionation was studied.
  39. [39]
    Separation and Purification of ω-6 Linoleic Acid from Crude Tall Oil
    Feb 2, 2020 · The objective of this work was to present a method for the isolation of high-value linoleic acid (LA), an omega (ω)-6 essential fatty acid, from CTO.
  40. [40]
    Increased accumulation of fatty acids in engineered Saccharomyces ...
    Mar 25, 2025 · Co-overexpression of Mdm1 and selected lipases significantly improved the biosynthesis of FAs and linoleic acid in the engineered S. cerevisiae.
  41. [41]
    Optimized production and enrichment of α-linolenic acid by ...
    Several free fatty acids which are commonly found in algae, such as, α-linolenic acid, linoleic acid, and tri- and monohydroxy fatty acids have been associated ...
  42. [42]
    Fatty Acid Desaturases, Polyunsaturated Fatty Acid Regulation, and ...
    In humans, PUFAs are synthesized by fatty acid desaturases ... Both LA and ALA are referred to as dietary essential fatty acids because humans cannot synthesize ...Missing: reason | Show results with:reason
  43. [43]
  44. [44]
    Essential Fatty Acids: The Work of George and Mildred Burr - PMC
    Oct 12, 2012 · The Burrs established that the fat-deprived rats could not be cured with saturated fatty acids, such as stearic, palmitic, and lauric acids.
  45. [45]
    Essential Fatty Acid Deficiency - Nutritional Disorders - Merck Manuals
    Signs include scaly dermatitis, alopecia, thrombocytopenia, and, in children, intellectual disability.
  46. [46]
    Essential fatty acid deficiency in parenteral nutrition: Historical ...
    Feb 17, 2025 · The first reported deficiency of alpha-linolenic acid in humans was described in 1982 when a 6-year-old child receiving parenteral nutrition ( ...
  47. [47]
    Linoleic Acid - ScienceDirect.com
    The level of essentiality in infants could be as low as 0.5–2.0% of energy and deprivation of linoleic acid (i.e., fat-free intravenous feeding) can result in ...Missing: threshold | Show results with:threshold
  48. [48]
    [PDF] Essential Fatty Acid Deficiency
    Essential fatty acid deficiency (EFAD) may occur in both the inpatient and outpatient setting. Patients with malabsorptive disorders as a result of ...
  49. [49]
    New insights into the molecular mechanism of intestinal fatty acid ...
    Intestinal uptake of lipids. The mixed micelles in the small intestinal lumen promote the absorption of fatty acids and cholesterol by facilitating transport ...
  50. [50]
    Intestinal CD36 and Other Key Proteins of Lipid Utilization: Role in ...
    Here, we review the regulation of enterocyte FA uptake and its function in lipid absorption including prechylomicron formation, assembly and transport.Intestinal Cd36 And Other... · Chylomicron Formation · Role Of Fabp1 And Cd36 In...
  51. [51]
    Regulation of Chylomicron Secretion: Focus on Post-Assembly ...
    This review examines recent advances in our understanding of the regulation of CM secretion in relation to mobilization of intestinal lipid stores.
  52. [52]
    Fat Absorption and Lipid Metabolism in Cholestasis - NCBI - NIH
    In this chapter, we will concentrate on digestion, absorption, and metabolism of the main dietary lipids TAG, PC, cholesterol, and fat-soluble vitamins.Intestinal Lipid Absorption · Translocation · Lipoprotein-Metabolizing...
  53. [53]
    Dihomo-γ-Linolenic Acid (20:3n-6)—Metabolism, Derivatives, and ...
    Dihomo-γ-linolenic acid (DGLA, 20:3n-6) is a polyunsaturated fatty acid (PUFA) that is usually present in low proportions in mammals but has recently emerged as ...
  54. [54]
    Identification of a fatty acid delta6-desaturase deficiency in human ...
    This is the first inherited abnormality in human PUFA metabolism shown to be associated with a Delta6-desaturase deficiency.
  55. [55]
    Δ-6 Desaturase Substrate Competition: Dietary Linoleic Acid ... - NIH
    Feb 27, 2013 · This pathway, commonly referred to as the “Sprecher pathway”, can convert the two essential polyunsaturated fatty acids (PUFA) linoleic acid (LA ...
  56. [56]
    Increasing dietary linoleic acid does not increase tissue arachidonic ...
    Jun 10, 2011 · Decreasing dietary linoleic acid by up to 90% was not significantly correlated with changes in arachidonic acid levels in the phospholipid pool ...
  57. [57]
    Loss of delta-6-desaturase activity as a key factor in aging - PubMed
    D6D is an enzyme which converts cis-linoleic acid to gamma-linolenic acid (GLA). Other factors which inhibit D6D activity are diabetes, alcohol and ...Missing: dihomo- | Show results with:dihomo-
  58. [58]
    Age-associated changes in circulatory fatty acids - PubMed Central
    Nov 30, 2022 · Total n-6 PUFA decreased with advancing age, primarily due to decreased LA and AA levels. The percentage of LA, the essential n-6 PUFA, ...
  59. [59]
    FADS1-FADS2 genetic polymorphisms are associated with fatty acid ...
    Aug 29, 2018 · Our findings suggest that genetic variants in the FADS region are major genetic modifiers that can regulate fatty acid metabolism through ...
  60. [60]
    Genetic Variants in the FADS Gene: Implications for Dietary ...
    Genetic variants within the fatty acid desaturase (FADS) cluster are determinants of long chain polyunsaturated fatty acid (LC-PUFA) levels in circulation, ...
  61. [61]
    Health Implications of High Dietary Omega-6 Polyunsaturated Fatty ...
    Since LA and ALA are metabolized by the same set of enzymes, a natural competition exists between these two fatty acids, whereby delta-5-desaturase and delta-6- ...<|control11|><|separator|>
  62. [62]
    Quantifying conversion of linoleic to arachidonic and other n-6 ...
    Conversion of LA to AA occurs by sequential Δ6 desaturation, elongation, and Δ5 desaturation reactions, passing though γ-linolenic acid (γ-LNA, 18:3n-6) and ...
  63. [63]
    Metabolism pathways of arachidonic acids: mechanisms ... - Nature
    Feb 26, 2021 · The COXs, which generate prostanoids, i.e., prostaglandins (PGs) and thromboxane A2 (TXA2), were the first enzymes reported to metabolize AA.
  64. [64]
    13-Hydroxyoctadecadienoic acid (13-HODE) metabolism ... - PubMed
    ... acid via the cyclooxygenase pathway, and 13-HODE, which is synthesized from linoleic acid via the lipoxygenase pathway. PGI2 is synthesized following cell ...
  65. [65]
    The role of prostacyclin in vascular tissue - PubMed
    Prostacyclin (PGI2) generated by the vascular wall is a potent vasodilator, and the most potent endogenous inhibitor of platelet aggregation so far discovered.
  66. [66]
    Physiology, Thromboxane A2 - StatPearls - NCBI Bookshelf
    [20] The vasoconstriction caused by TxA2 aids in platelet aggregation because platelets are close to each other, which leads to greater clot formation.
  67. [67]
    Pro- and Anti-Inflammatory Prostaglandins and Cytokines in Humans
    Jun 1, 2023 · Two main groups of molecules, the prostaglandins (PG) and the cytokines, have been discovered and play a major role in inflammatory processes.
  68. [68]
    [PDF] Appendix E‐2.43: Saturated Fat and Risk of CVD Evidence Portfolio
    A 5% of energy increment in linoleic acid intake replacing energy from saturated fat intake was associated with a 9% lower risk of CHD events and a 13% lower ...
  69. [69]
    Dietary Linoleic Acid and Risk of Coronary Heart Disease
    In a meta-analysis of 22 studies, including case-control ... Linoleic acid lowers LDL cholesterol without a proportionate displacement of saturated fatty acid.
  70. [70]
    The Relation between Insulin Sensitivity and the Fatty-Acid ...
    Jan 28, 1993 · Increasing the content of polyunsaturated fatty acids within cell membranes in cultured cells increases membrane fluidity, the number of insulin ...
  71. [71]
    Dietary Intake of Linoleic Acid, Its Concentrations, and the Risk of ...
    Sep 1, 2021 · High intake of LA was associated with a 6% lower risk of T2DM (summary relative risk [RR] 0.94, 95% CI 0.90, 0.99; I 2 = 48.5%).Introduction · Methods · Results · Discussion
  72. [72]
    Beneficial effects of linoleic acid on cardiometabolic health: an update
    Sep 12, 2024 · A robust evidence base, however, demonstrates that higher intakes and blood levels of LA are associated with improved cardiometabolic health outcomes.
  73. [73]
    The importance of the omega-6/omega-3 fatty acid ratio in ... - PubMed
    In the secondary prevention of cardiovascular disease, a ratio of 4/1 was associated with a 70% decrease in total mortality. A ratio of 2.5/1 reduced rectal ...
  74. [74]
    Serum Omega-6/Omega-3 Ratio and Risk Markers for ... - NIH
    However, the WHO recommendation of omega-6/omega-3 ratio is 5 - 8 which should form 1% - 2% of total energy intake per day [2]. A very high omega-6/omega-3 ...
  75. [75]
    evaluation of recovered data from the Sydney Diet Heart Study and ...
    Feb 5, 2013 · An updated meta-analysis of linoleic acid intervention trials showed no evidence of cardiovascular benefit. ... risk of major cardiovascular ...<|control11|><|separator|>
  76. [76]
    Pro-resolving lipid mediators: regulators of inflammation ... - Nature
    Jul 19, 2021 · SPMs include lipoxins, which are generated from the ω-6 PUFA arachidonic acid, and resolvins, protectins and maresins (MaRs), which are derived ...
  77. [77]
    Linoleic Acid—A Feasible Preventive Approach for Visceral ...
    Arachidonic acid (AA, ω-6) is the derivative of LA and is known to set a background for instant innate immune response with its metabolites, i.e., eicosanoids.
  78. [78]
    Linoleic acid supplementation results in increased arachidonic ... - NIH
    We hypothesized that increased conversion of linoleic acid to arachidonic acid in CF leads to increased levels of arachidonate-derived proinflammatory ...
  79. [79]
    Synopsis of arachidonic acid metabolism: A review - ScienceDirect
    It provides a comprehensive outline on AA metabolic pathways, enzymes and signaling cascades, in order to develop new perspectives in disease treatment and ...
  80. [80]
    Long-chain polyunsaturated fatty acids are consumed during ...
    Long-chain polyunsaturated fatty acids are consumed during allergic inflammation and affect T helper type 1 (Th1)- and Th2-mediated hypersensitivity differently.
  81. [81]
    Long Chain Fatty Acids as Modulators of Immune Cells Function
    Jul 1, 2021 · In this review, we discuss the cellular responses and intracellular mechanisms activated by LCFAs, such as oleic acid, linoleic acid, palmitic ...<|control11|><|separator|>
  82. [82]
    Lipid functions in skin: Differential effects of n-3 polyunsaturated fatty ...
    Indeed, the essential fatty acid linoleic acid (LA; C18:2n-6) is of particular significance to skin health, as it contributes to the formation of ceramides ...
  83. [83]
    Topical clindamycin 1% vs. linoleic acid-rich phosphatidylcholine ...
    It has been shown that topical linoleic acid rich-phosphatidylcholine seems to be effective in normalization of follicular hyperkeratinization, ...
  84. [84]
    The benefit of a ceramide-linoleic acid-containing moisturizer as an ...
    Jul 28, 2019 · The results showed that tropical applications of an LA-Cer-containing moisturizer in combination with a topical glucocorticoid accelerated the ...
  85. [85]
    Anti-Inflammatory and Skin Barrier Repair Effects of Topical ... - NIH
    Linoleic acid, for example, has a direct role in maintaining the integrity of the water permeability barrier of the skin [46,47].
  86. [86]
    Relevance of Fatty Acids to Sperm Maturation and Quality - PMC - NIH
    Feb 5, 2020 · High level of PUFAs in the sperm membrane assures higher fluidity of sperm cells, hence increasing the kinetic traits of the sperm [56–58].
  87. [87]
    The Effect of Maternal Exposure to a Diet High in Fats and ...
    Linoleic and arachidonic fatty acids and their potential relationship with inflammation, pregnancy, and fetal development. Curr. Med. Chem. 2023 doi ...
  88. [88]
    Walnut ointment promotes full-thickness burning wound healing
    Nov 28, 2022 · Conclusions: LA, which is the main components in WO can promote full-thickness burning wounds (FBWs) by stimulating cell proliferation and ...Missing: studies | Show results with:studies
  89. [89]
    The Role of Moisturizers in Addressing Various Kinds of Dermatitis
    High linoleic acid concentrations are believed to accelerate skin barrier repair and development, improving skin hydration, and ameliorate atopic dermatitis ...
  90. [90]
    Linoleic acid - Tuscany Diet
    Its name derives from the Latin linon, meaning flax, plus oleic, meaning oil. It was isolated by Sacc F. in 1844 from linseed oil, the structure was clarified ...
  91. [91]
    Discovery of essential fatty acids - PMC - PubMed Central
    The discovery of essential fatty acids is one of the great advances in lipid research. It reversed the commonly held belief that dietary fat was merely a ...
  92. [92]
    Discovery of essential fatty acids - PubMed
    The Burrs surmised that other unsaturated fatty acids were essential and subsequently demonstrated that linolenic acid, the omega-3 fatty acid analog of ...
  93. [93]
    [PDF] The Chemical Constitution of Natural Fats - Semantic Scholar
    The Chemical Constitution of Natural Fats · T. Hilditch · Published in British Journal of Nutrition 1 December 1949 · Chemistry.
  94. [94]
    Re-evaluation of the traditional diet-heart hypothesis - The BMJ
    Apr 12, 2016 · The traditional diet-heart hypothesis predicts that replacing saturated fat with vegetable oil rich in linoleic acid will reduce coronary heart ...
  95. [95]
    FADS genetic variants and ω-6 polyunsaturated fatty acid ... - NIH
    Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism. ... of omega-6 and omega-3 polyunsaturated fatty acids.
  96. [96]
    Dietary Linoleic Acid and Risk of Coronary Heart Disease
    This systematic review and meta-analysis support a significant inverse association between dietary LA intake, when replacing either carbohydrates or saturated ...
  97. [97]
    Linoleic Acid, Vegetable Oils & Inflammation - PMC - NIH
    A recently published systematic review of 15 clinical trials failed to find any support for the “diet LA causes inflammation hypothesis.”Missing: 2020s | Show results with:2020s
  98. [98]
    Linoleic acid and breast cancer risk: a meta-analysis - PMC - NIH
    This meta-analysis indicated that both dietary linoleic acid intake and serum linoleic acid level were associated with decreased risk of breast cancer.
  99. [99]
    Omega-6 vegetable oils as a driver of coronary heart disease - NIH
    Sep 26, 2018 · These oxidised linoleic acid metabolites can then induce direct toxic effects to the endothelium such as inflammation, reactive oxygen species ...
  100. [100]
    Diet high in linoleic acid dysregulates the intestinal ... - NIH
    Jul 3, 2023 · Diet high in linoleic acid dysregulates the intestinal endocannabinoid system and increases susceptibility to colitis in Mice - PMC.
  101. [101]
    Alpha-Linolenic and Linoleic Fatty Acids in the Vegan Diet - NIH
    More research is needed on the long-term effects of low erythrocyte and adipose EPA and DHA and chronic disease risk in both VGNs and omnivores. 8 ...